CD36 and type 2 diabetes mellitus: We know from a previous work [15] that cells derived from obese type 2 diabetic patients display an impaired capacity to respond to metabolic stimuli at the level of mitochondrial activity, which could explain the difference in lipid content between OBT2D and Control cells even when control cells showed a similar cell surface FAT/CD36 content than OBT2D cells.